S&P also raised its underlying rating for the system’s variable-rate demand bonds from “A+” to “AA-.”
The ratings reflect Aspirus’ sound financial profile, with good debt and liquidity metrics even considering recent capital projects, along with the health system’s growth in recent years.
The rating outlook is stable.
More articles on healthcare finance:
California dialysis initiative prompts hundreds of millions in spending
Ballot measures in 2 California cities take aim at healthcare costs
Mississippi hospital ends ER fee for nonemergencies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
